UA111345U - METHOD OF PREVENTION OF SPIKE DISEASE AFTER LAPAROSCOPIC INTERVENTIONS AFTER EARLY PREGNANCY - Google Patents

METHOD OF PREVENTION OF SPIKE DISEASE AFTER LAPAROSCOPIC INTERVENTIONS AFTER EARLY PREGNANCY Download PDF

Info

Publication number
UA111345U
UA111345U UAU201604143U UAU201604143U UA111345U UA 111345 U UA111345 U UA 111345U UA U201604143 U UAU201604143 U UA U201604143U UA U201604143 U UAU201604143 U UA U201604143U UA 111345 U UA111345 U UA 111345U
Authority
UA
Ukraine
Prior art keywords
prevention
early pregnancy
laparoscopic interventions
spike disease
laparoscopic
Prior art date
Application number
UAU201604143U
Other languages
Ukrainian (uk)
Inventor
Інна Володимирівна Бирчак
Світлана Альбертівна Куріцина
Original Assignee
Вищий Державний Навчальний Заклад України "Буковинський Державний Медичний Університет"
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Вищий Державний Навчальний Заклад України "Буковинський Державний Медичний Університет" filed Critical Вищий Державний Навчальний Заклад України "Буковинський Державний Медичний Університет"
Priority to UAU201604143U priority Critical patent/UA111345U/en
Publication of UA111345U publication Critical patent/UA111345U/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Спосіб профілактики спайкової хвороби після лапароскопічних втручань з приводу позаматкової вагітності шляхом використання протиспайкового засобу. Інтраопераційно (після завершення основного етапу) в черевну порожнину вводять поліфункціональний протиспайковий засіб Дефенсаль в дозі 250 мл з експозицією через 12 год. та наступною аспірацією вмісту.Method for the prevention of adhesions after laparoscopic interventions for ectopic pregnancy by using an anti-adhesive agent. Intraoperatively (after the completion of the main stage), a multifunctional anti-adhesive agent Defensal is injected into the abdominal cavity at a dose of 250 ml with an exposure after 12 hours. and subsequent aspiration of the content.

UAU201604143U 2016-04-15 2016-04-15 METHOD OF PREVENTION OF SPIKE DISEASE AFTER LAPAROSCOPIC INTERVENTIONS AFTER EARLY PREGNANCY UA111345U (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
UAU201604143U UA111345U (en) 2016-04-15 2016-04-15 METHOD OF PREVENTION OF SPIKE DISEASE AFTER LAPAROSCOPIC INTERVENTIONS AFTER EARLY PREGNANCY

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UAU201604143U UA111345U (en) 2016-04-15 2016-04-15 METHOD OF PREVENTION OF SPIKE DISEASE AFTER LAPAROSCOPIC INTERVENTIONS AFTER EARLY PREGNANCY

Publications (1)

Publication Number Publication Date
UA111345U true UA111345U (en) 2016-11-10

Family

ID=57445484

Family Applications (1)

Application Number Title Priority Date Filing Date
UAU201604143U UA111345U (en) 2016-04-15 2016-04-15 METHOD OF PREVENTION OF SPIKE DISEASE AFTER LAPAROSCOPIC INTERVENTIONS AFTER EARLY PREGNANCY

Country Status (1)

Country Link
UA (1) UA111345U (en)

Similar Documents

Publication Publication Date Title
CY1124404T1 (en) BILE ACID DERIVATIVES AS FXR/TGR5 AGENTS AND METHODS OF USING THEREOF
EA201991693A1 (en) PYRIDINE DERIVATIVE AS ASK1 INHIBITOR AND METHOD FOR PRODUCING AND USE
EA201790398A1 (en) METHODS OF TREATING LIVER DISEASES
BR112019011702A2 (en) treating a gastrointestinal tract disease with an il-12 / il-23 inhibitor released using an ingestible device
EA201692436A1 (en) MEDICAL APPLICATION
BR112017005790A2 (en) vascular repair devices and methods of use
PH12017501652B1 (en) Kv1.3 inhibitors and their medical application
BR112016001678A2 (en) COMPOSITION, METHOD OF MANUFACTURE OF A TABLET, TABLET, UNIT DOSAGE FORM, ARTICLE OF MANUFACTURE, AND, USE OF A COMPOSITION, TABLET OR UNIT DOSAGE FORM
CO2021005532A2 (en) Quinoline derivatives as inhibitors of integrin alpha4beta7
EP4233902A3 (en) Treatment of a disease of the gastrointestinal tract with an integrin inhibitor
MX2018004309A (en) Combination therapies for treating cancer.
PH12017501067B1 (en) Dihydroindolizinone derivative
EA201500851A1 (en) ESTRA-1,3,5 (10), 16-TETRAEN-3-CARBOXAMIDES TO INHIBIT 17β-HYDROXYSTEROID DEGYDROGENASE (AKR1C3)
BR112016001544A8 (en) pharmaceutical compositions for intraocular administration comprising an antibacterial agent and an anti-inflammatory agent
BR112017014361A2 (en) methods for perfecting cell therapy
EA201691918A1 (en) PHARMACEUTICAL COMPOSITIONS OF KINAZ INHIBITOR KINAZ OF THE RAF FAMILY, METHODS OF THEIR PRODUCTION AND METHODS OF THEIR USE
SA519410865B1 (en) Coumarin-like Cyclic Compound as MEK Inhibitor and Use Thereof
EA201792264A1 (en) METHODS OF TREATING INFLAMMATORY DISEASES
BR112015024897A2 (en) phenyl derivative
UA111345U (en) METHOD OF PREVENTION OF SPIKE DISEASE AFTER LAPAROSCOPIC INTERVENTIONS AFTER EARLY PREGNANCY
CL2022001314A1 (en) Drug for the treatment or prevention of cerebral hemorrhage, and method for the treatment or prevention of cerebral hemorrhage with said drug
BR112016026422A2 (en) pharmaceutical solution comprising dopamine for use in the treatment of parkinson's disease
BR112017007031A2 (en) pharmaceutical composition for subcutaneous administration, method of treating a patient suffering from trauma or blood clotting disease, kit of parts, and dosage form of a pharmaceutical composition
UA118051U (en) METHOD OF REHABILITATION OF WOMEN AFTER SURGERY IN GYNECOLOGY
EA201890101A1 (en) NEW SCHEME TREATMENT TYACUMICINE CONNECTION